N.V. Neroeva
Helmholtz National Medical Research Center of Eye Diseases
V.V. Neroev
Helmholtz National Medical Research Center of Eye Diseases;
A.I. Evdokimov Moscow State University of Medicine and Dentistry
L.A. Katargina
Helmholtz National Medical Research Center of Eye Diseases
M.V. Ryabina
Helmholtz National Medical Research Center of Eye Diseases
P.A. Ilyukhin
Helmholtz National Medical Research Center of Eye Diseases
A.G. Karmokova
Helmholtz National Medical Research Center of Eye Diseases
O.A. Losanova
Helmholtz National Medical Research Center of Eye Diseases
A.M. Maybogin
Helmholtz National Medical Research Center of Eye Diseases
A.E. Kharitonov
Federal Research and Clinical Center of Physical-Chemical Medicine
A.V. Eremeev
Federal Research and Clinical Center of Physical-Chemical Medicine
M.A. Lagarkova
Federal Research and Clinical Center of Physical-Chemical Medicine
Experimental stem cell replacement transplantation in retinal pigment epithelium atrophy
Journal: Russian Annals of Ophthalmology. 2022;138(3): 7‑15
Views: 970
Downloaded: 32
To cite this article:
Neroeva NV, Neroev VV, Katargina LA, Ryabina MV, Ilyukhin PA, Karmokova AG, Losanova OA, Maybogin AM, Kharitonov AE, Eremeev AV, Lagarkova MA. Experimental stem cell replacement transplantation in retinal pigment epithelium atrophy. Russian Annals of Ophthalmology.
2022;138(3):7‑15. (In Russ., In Engl.)
https://doi.org/10.17116/oftalma20221380317
To develop and evaluate the results of the modified surgical technique for transplantation of retinal pigment epithelium (RPE) differentiated from human induced pluripotent stem cells (iPSC-RPE) in the form of a cell suspension into the subretinal space of rabbits with previously induced RPE atrophy.
The study was conducted on 10 New Zealand albino rabbits (20 eyes). One month after modeling RPE atrophy and retinal degeneration, rabbits were subjected to subretinal transplantation of iPSC-RPE cells in the form of a cell suspension. To prevent reflux of iPSC-RPE into the vitreal cavity, the injection site was sealed with 2—3 drops of autologous platelet-rich plasma (PRP). All rabbits underwent spectral optical coherence tomography (SOCT) and autofluorescence studies on the Heidelberg Spectralis system («Heidelberg Engineering», Germany). Enucleated animal eyes were studied with morphological and immunohistochemical methods.
In this study we developed and evaluated a modified surgical technique of transplantation of iPSC-RPE in the form of a cell suspension into the subretinal space of rabbits with induced RPE atrophy. It was found that the use of PRP helps seal the defect and prevents cell suspension reflux into the vitreous cavity, effectively minimizing intra- and postoperative complications. Morphological in vivo study and examination of histological sections showed that implantable iPSC-RPEs were correctly integrated and adhered to the choroid in the surgery site. Immunohistochemical analysis involving fluorescence-marked antibodies confirmed the survival of iPSC-RPE integrated into the retina of model animals.
This method improves the technology of iPSC-RPE transplantation on preclinical stages of the study, revealing new prospects in the treatment of degenerative diseases of the retina and the possibility of a personalized approach.
Keywords:
Authors:
N.V. Neroeva
Helmholtz National Medical Research Center of Eye Diseases
V.V. Neroev
Helmholtz National Medical Research Center of Eye Diseases;
A.I. Evdokimov Moscow State University of Medicine and Dentistry
L.A. Katargina
Helmholtz National Medical Research Center of Eye Diseases
M.V. Ryabina
Helmholtz National Medical Research Center of Eye Diseases
P.A. Ilyukhin
Helmholtz National Medical Research Center of Eye Diseases
A.G. Karmokova
Helmholtz National Medical Research Center of Eye Diseases
O.A. Losanova
Helmholtz National Medical Research Center of Eye Diseases
A.M. Maybogin
Helmholtz National Medical Research Center of Eye Diseases
A.E. Kharitonov
Federal Research and Clinical Center of Physical-Chemical Medicine
A.V. Eremeev
Federal Research and Clinical Center of Physical-Chemical Medicine
M.A. Lagarkova
Federal Research and Clinical Center of Physical-Chemical Medicine
Received:
21.09.2020
Accepted:
23.12.2020
List of references:
Close metadata
Email Confirmation
An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.
Email Confirmation
Log in to the site using your account in one of the services
We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.